13F Holdings
中文EN

CBT CABOT CORP

Miscellaneous Chemical Products · NYSE · SEC CIK 16040 · Fiscal year ends 09/30

Financial factors as of 2026-06-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY-4.7%
TTM net income YoY-55.3%
TTM EPS YoY-53.3%
Revenue 3-yr CAGR-3.8%
Net income 3-yr CAGR-14.6%

Margins

Gross margin22.7%
Operating margin13.6%
Net margin5.2%
FCF margin7.7%
EBITDA margin18.5%

Returns

ROE12.1%
ROA4.9%
ROIC (approx.)10.9%
Asset turnover0.93x

Leverage & solvency

Liabilities / assets56.4%
Debt / equity0.68x
Current ratio1.47x
Interest coverage6.66x

Cash quality & payout

Operating cash flow / net income2.62x
Accruals ratio-7.9%
Payout ratio51.1%
Capex / revenue5.9%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-09-30FY20242024-09-30FY20232023-09-30FY20222022-09-30FY20212021-09-30
Income statement
Revenue$3.71B$3.99B$3.93B$4.32B$3.41B
Cost of revenue$2.77B$3.03B$3.09B$3.44B$2.61B
Gross profit$940.00M$960.00M$839.00M$885.00M$799.00M
R&D expense$59.00M$63.00M$57.00M$55.00M$56.00M
SG&A expense$260.00M$283.00M$253.00M$258.00M$289.00M
Operating income$621.00M$614.00M$526.00M$389.00M$454.00M
Interest expense$76.00M$81.00M$90.00M$56.00M$49.00M
Pretax income$565.00M$529.00M$451.00M$335.00M$406.00M
Income tax$196.00M$111.00M-$28.00M$102.00M$123.00M
Net income$331.00M$380.00M$445.00M$209.00M$250.00M
EBITDA$775.00M$765.00M$670.00M$535.00M$614.00M
EPS (basic)6.076.797.793.654.35
EPS (diluted)6.026.727.733.624.34
Dividends declared per share1.761.661.541.481.40
Weighted avg. shares (diluted)54.20M55.70M56.50M56.90M56.80M
Balance sheet
Cash & equivalents$258.00M$223.00M$238.00M$206.00M$168.00M
Inventory$504.00M$552.00M$585.00M$664.00M$523.00M
Current assets$1.54B$1.60B$1.63B$1.82B$1.43B
PP&E, net$1.71B$1.53B$1.41B$1.27B$1.38B
Goodwill$134.00M$133.00M$134.00M$129.00M$140.00M
Intangibles$55.00M$53.00M$60.00M$63.00M$100.00M
Total assets$3.81B$3.74B$3.60B$3.52B$3.31B
Current liabilities$957.00M$772.00M$822.00M$1.10B$1.15B
Short-term debt$260.00M$8.00M$8.00M$7.00M$373.00M
Long-term debt$856.00M$1.09B$1.09B$1.09B$717.00M
Total debt$1.12B$1.09B$1.10B$1.10B$1.09B
Total liabilities$2.11B$2.15B$2.20B$2.49B$2.22B
Shareholders' equity$1.55B$1.43B$1.26B$898.00M$947.00M
Net debt$858.00M$872.00M$864.00M$890.00M$922.00M
Shares outstanding52.84M54.30M55.24M56.25M56.73M
Cash flow statement
Operating cash flow$665.00M$692.00M$595.00M$100.00M$257.00M
Capital expenditure$274.00M$241.00M$244.00M$211.00M$195.00M
Free cash flow$391.00M$451.00M$351.00M-$111.00M$62.00M
Investing cash flow-$298.00M-$235.00M-$214.00M-$118.00M-$186.00M
Financing cash flow-$336.00M-$415.00M-$403.00M$145.00M-$60.00M
Depreciation & amortization$154.00M$151.00M$144.00M$146.00M$160.00M
Stock-based compensation$24.00M$25.00M$20.00M$23.00M$21.00M
Dividends paid$96.00M$93.00M$88.00M$84.00M$80.00M
Share buybacks$168.00M$172.00M$98.00M$53.00M$3.00M

Free plan shows the latest 5 periods; Pro shows all 18 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.